IBNSINA PHARMA

The current price of ISPH is 2.700 EGP — it has decreased by 4.26% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange IBNSINA PHARMA stocks are traded under the ticker ISPH.

IBNSINA PHARMA is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.

ISPH stock is 10.51% volatile and has beta coefficient of 0.01. Check out the list of the most volatile stocks — is IBNSINA PHARMA there?

IBNSINA PHARMA revenue for the last quarter amounts to ‪4.93 B‬ EGP despite the estimated figure of ‪4.93 B‬ EGP. In the next quarter revenue is expected to reach ‪6.50 B‬ EGP.

Yes, you can track IBNSINA PHARMA financials in yearly and quarterly reports right on TradingView.

ISPH net income for the last quarter is ‪32.09 M‬ EGP, while the quarter before that showed ‪34.05 M‬ EGP of net income which accounts for −5.73% change. Track more IBNSINA PHARMA financial stats to get the full picture.

Today IBNSINA PHARMA has the market capitalization of ‪3.16 B‬, it has increased by 2.84% over the last week.

Like other stocks, ISPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IBNSINA PHARMA stock right from TradingView charts — choose your broker and connect to your account.

ISPH reached its all-time high on Mar 7, 2019 with the price of 8.767 EGP, and its all-time low was 1.101 EGP and was reached on Jul 5, 2022.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IBNSINA PHARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IBNSINA PHARMA stock shows the neutral signal. See more of IBNSINA PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on IBNSINA PHARMA future price: according to them, ISPH price has a max estimate of 4.60 EGP and a min estimate of 4.60 EGP. Read a more detailed IBNSINA PHARMA forecast: see what analysts think of IBNSINA PHARMA and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IBNSINA PHARMA EBITDA is ‪1.33 B‬ EGP, and current EBITDA margin is 4.01%. See more stats in IBNSINA PHARMA financial statements.